Zydus Lifesciences shares fell up to 6% on Monday to day’s low at Rs 1,109 on BSE after the company announced acquisition of 50% stake in Sterling Biotech from existing owner Perfect Day for Rs 550 crore. Nomura maintained its neutral stance with a target price of Rs 1,020 while Motilal Oswal also stuck to … Read more
Mumbai : India could see inflows of up to $3 billion by the end of August due to the scheduled inclusion of select stocks by index provider MSCI in its benchmarks. In addition to the inclusion of seven stocks into the Global Standard index, MSCI will also increase the weight of HDFC Bank in the … Read more
Rail Vikas Nigam (RVNL) and Vodafone Idea stand among 7 stocks granted seats at the MSCI’s Global Standard index while Bandhan Bank was excluded as part of the global index service provider’s August rejig. Due to this inclusion, RVNL is likely to attract passive fund inflows worth $219 million while Vodafone Idea may likely be … Read more
The average market capitalisation cut-off for a stock to make it to the largecap category in the upcoming Amfi semi-annual categorisation is expected to be Rs 84,000 crore compared to an average of Rs 67,000 crore in the six months ending December 2023, Nuvama said in a note. Meanwhile, the midcap threshold is likely to … Read more
“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus Life is not trading at much higher valuations like Sun, therefore we feel that Zydus Life is also a second stock which can see good … Read more
Recent trading sessions have experienced significant volatility in the Indian markets, driven by concerns related to the budget and geopolitical developments in the Red Sea region. However, these corrections also offer a great opportunity for investors to enter good-quality stocks.In light of the prevailing conditions, three stocks have formed a strong setup on the technical … Read more
